ResearcherDalian Medical UniversityNo recent work listed

Yanxia Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1938-4118; OpenAlex author ID A5100764169. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 2

Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysis. Co-author DOI 10.1186/s12881-020-0975-8 ↗
Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with enhanced activity against pancreatic cance… Co-author DOI 10.1016/j.bmc.2017.09.041 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lian Li · 1 shared paper, 2020 · strength 0.15
- Paper Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysis. DOI 10.1186/s12881-020-0975-8 ↗
Xiaodong Ma · 1 shared paper, 2017 · strength 0.06
- Paper Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with en… DOI 10.1016/j.bmc.2017.09.041 ↗
Changyuan Wang · 1 shared paper, 2017 · strength 0.06
- Paper Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with en… DOI 10.1016/j.bmc.2017.09.041 ↗
He Liu · 1 shared paper, 2017 · strength 0.06
- Paper Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with en… DOI 10.1016/j.bmc.2017.09.041 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.